Multifunctional coprocessed excipients for improved tabletting performance

Expert Opinion on Drug Delivery

Volumn 6, Issue 2, 2009, Pages 197-208

  Saha, Sumit ^a   Shahiwala, Aliasgar F ^a  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Coprocessed excipients; Coprocessing; Direct compression; Tablet

Indexed keywords

ADVANTOSE FS 95; AVICEL CE 15; CEFIXIME; CELLULOSE; COMPRESSOL S; DIPAC; ELCEMA; EXCIPIENT; FOLIC ACID; FORMAXX; GLIBENCLAMIDE; IBUPROFEN; LACTOSE; LUDIPRESS; MICROCELAC; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; PHARMATOSE DCL 40; POLYOL; PROSOLV; SORBITOL; STARLAC; SUGAR; UNCLASSIFIED DRUG; XYLITAB; CARBOHYDRATE; DRUG; SUGAR ALCOHOL;

DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MIXTURE; DRUG QUALITY; DRUG SAFETY; PARTICLE SIZE; REVIEW; TABLET COMPRESSION; TABLET MANUFACTURE; TENSILE STRENGTH; CHEMISTRY; DRUG APPROVAL; METHODOLOGY; TABLET;

CARBOHYDRATES; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; DRUG APPROVAL; EXCIPIENTS; LACTOSE; PHARMACEUTICAL PREPARATIONS; SUGAR ALCOHOLS; TABLETS;

EID: 66949143392     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240802708978     Document Type: Review

References (83)

1. Freeman T. Powder Characterization for Formulation and Processing. Pharm Technol 2008 (Pubitemid 351694210)
2. Shangraw RF. Compressed tablets by direct compression. In: Leiberman HA, Lachman L, Schwatz JB, editors, Pharmaceutical dosage forms: tablets. Volume 1. New York: Marcel Dekker. Inc., 1990. p. 195-246
3. Steinberg M, Blecher L, Mercill A. From inactive ingredients to pharmaceutical excipients. Pharm Technol 2001;25(7):62-64 (Pubitemid 32685622)
4. Nachaegari SK, Bansal AK. Coprocessed excipients for solid dosage form. Pharm Technol 2004;28:52-65 • Comprehensive early review on coprocessed excipients.
5. Moreton RC. Tablet Excipients to the Year 2001: A Look into the Crystal Ball. Drug Dev Ind Pharm 1996;22(1):11-23
6. Modleszewski JJ, Ballard DA. FMC Corporation(Philadelphia, PA) assignee Coprocessed Galactomannan - Glucomannan. US5498436; 1996
7. Mehra DK, West KP, Wiggins JD. FMC Coporation (Philadelphia), assignee Coprocessed microcrystaline cellulose and calcium carbonate and its preparation. US4744987; 1988 • First successful attempt to produce coprocessed excipients.
8. Bolhius GK, Chowhan ZT. Materials for direct compaction. In: Alderborn G, Nystrom C, editors, Pharmaceutical powder compaction technology. Volume 7. New York: Marcel Dekker Inc., 1996. p. 419-500
9. Reimerds D. The Near Future of Tablet Excipients. Manufacturing chemist 1993;64(7):14-15
10. Compressol S. Available from: http://www.spipharma.com/downloads/ Products/Excipients/Compressol-S/CompressolSTech.pdf.
11. Armstrong NA, Roscheisen G, Al-Aghbar MR. Cellactose As a Tablet Diluent. Manuf Chem 1996;67:25-26 (Pubitemid 26381885)
12. Sherwood BE, Becker JW. A New Class of High Functionality Excipients: Silicified Microcrystalline Cellulose. Pharm Technol 1998;20:78-88 (Pubitemid 28471746)
13. Morris LE, Moore JC, Schwartz JB. Characterization and performance of a new direct compression excipient for chewable tablets: Xylitab. Drug Dev Ind Pharm 1996;22(9-10):925-932
14. Flores LE, Arellano RL, Esquivel JJD. Study of Load Capacity of Avicel PH-200 and cellactose, Two Direct-Compression Excipients, Using Experimental Design. Drug Dev Ind Pharm 2000;26(4):465-469 (Pubitemid 30207721)
15. Felton LA, Garcia DI, Farmer R. Weight and Weight Uniformity of Hard Gelatin Capsules Filled with Microcrystalline Cellulose and Silicified Microcrystalline Cellulose. Drug Dev Ind Pharm 2002;28(4):467-472 (Pubitemid 34547883)
16. Veen BV, Bolhuis GK, Wu YS, et al. Compaction mechanism and tablet strength of unlubricated and lubricated (silicified) microcrystalline cellulose. Eur J Pharm Biopharm 2005;59(1):133-8 • Clearly explains the differences in the compaction properties between microcyrstalline cellulose and silicified microcrystalline cellulose.
17. Avicel CE 15: Microcrystalline Cellulose and Guar Gum. Available from: http://www.fmcbiopolymer.com/Portals/bio/Content/Docs/Pharmaceuticals/ Avicel%20CE-15.pdf
18. Parrott EL. Compression. In: Lieberman HA, Lachman L, Schwartz JB, editors, Pharmaceutical Dosage Forms: Tablets. Volume 2. Marcel Dekker Inc: New York, NY; 1990. p. 153-182
19. Jain S. Mechanical properties of powders for compaction and tableting: an overview. Pharm Sci Technol Today 1999;2(1):20-31 • A comprehensive review explaining the mechanical properties that are critical to understand powder processing for tabletting.
20. Shangraw RF. Compressed tablets by direct compression. In: Leiberman HA, Lachman L, Schwatz JB, editors, Pharmaceutical dosage forms: Tablets. Volume 2. New York: Marcel Dekker; 1990. p. 201-241
21. Casahoursat L, Lemagen G, Larrouture D. The use stress relaxation trials to characterize tablet capping. Drug Dev Ind Pharm 1988;14(15-17):2179-2199 (Pubitemid 18247640)
22. Picker KM. A new theoretical model to characterize the densification behavior of tableting materials. Eur J Pharm Biopharm 2000;49(3):267-73 • Introduction of a new theoretical 3-D model to characterize the deformation and densification behavior of tabletting materials.
23. Picker KM. The 3-D Model: Does Time Plasticity Represent the Influence of Tableting Speed? AAPS PharmSciTech 2003;4(4): E66
24. Picker KM. The 3-D Model: Comparison of Parameters Obtained From and by Simulating Different Tableting Machines. AAPS PharmSciTech 2003;4(3): E35 (Pubitemid 41086167)
25. Picker KM. The 3D model: explaining densification and deformation mechanisms by using 3D parameter plots. Drug Dev Ind Pharm 2004;30(4):413-25 • Explains the mechanisms and ideal characteristics of deforming tabletting excipients.
26. Nokhodchi A, Rubinstein MH, Ford JL. The effect of particle size and viscosity grade on the compaction properties of hydroxypropylmethylcellulose 2208. Int J Pharm 1995;126(1-2):189-197 (Pubitemid 26018578)
27. Nokhodchi A, Ford JL, Rowe PH, Rubinstein MH. The effects of compression rate and force on the compaction properties of different viscosity grades of hydroxypropylmethylcellulose 2208. Int J Pharm 1996;129(1-2):21-31 (Pubitemid 26098733)
28. Gupta P, Nachaegari SK, Bansal AK. Improved excipients functionality by coproceesing In: Katdare A, Chaubal MV, editors, Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems: CRC Press, 2006. p. 109-124
29. Sherwood BE, Staniforth JH, Hunter EA, J Rettenmaier & Soehne GmbH + Co. KG (Rosenberg DE), assignee. Pharmaceutical excipient having improved compressibility. US6858231; 2005
30. McGinley EJ, Tuason DC. FMC Corporation(Philadephia, PA), assignee. Fat-like bulking agent for aqueous foods comprising microcrystalline cellulose and a galactomannan gum. US5192569; 1993
31. Modliszewski JJ, Ballard AD. FMC Corporation(Philadelphia, PA), assignee Coprocessed galactomannan-glucomannan. US5498436; 1996
32. Pharmatose DCL 11. Product specification bulletin. Available from: http://signetchem.com/pdf/pharmatosedcl11.pdf.
33. Pharmatose DCL 21. Product specification bulletin. Available from: http://www.signetchem.com/pdf/pharmatosedcl21.pdf.
34. Microcrystalline cellulose. In: Wade A, Waller PJ, editors, Handbook of Pharmaeutical excipients: The Pharmaceutical Press, London; 1994
35. Ludipress. Technical information. Available from: http://www.makeni.com. br/Portals/Makeni/prod/boletim/Ludipress.pdf. [Accessed 2001 ]
36. Cellactose 80. Available from: http://www.meggle-pharma.de/en/products/ uebersicht/cellactose80/
37. Cellulose, Silicified Microcrystalline Cellulose. In: Rowe RC, Sheskey PJ, Owen SC, editors, Pharmaceutical excipients, 2005. p. 359-363
38. Starlac. Available from: www.meggle-pharma.de/en/product/uebersicht/ starlac.
39. Dressler JA, Wagner KG. A corn starch/[alpha]-lactose monohydrate compound as a directly compressible excipient. Pharm Technol Eur 2003
40. Whiteman M, Yarwood RJ. Evaluaton of six lactose- based materials as direct compression tablet excipients. Drug Dev Ind Pharm 1988;14:1023-1040 (Pubitemid 18154547)
41. AshrafiM, Chowdhury JA, Reza MS. Controlled Release of Metformin Hydrochloride I. In vitro Release from Physical Mixture Containing Xanthan Gum as Hydrophilic Rate Retarding Polymer. Dhaka University. J Pharm Sci 2005;4(1)
42. Munoz-Ruiz MA, Borrero-Rubio JM, Jimenez-Castellanos MR. Rheology of a New Excipient for Direct Compression: Ludipress. Pharm Acta Helv 1992;67:223-226
43. Munoz-Ruiz MA, Perales CM, Antequeva VV, Villar T. Rheology and Compression Characteristics of Lactose Based Direct Compression Excipients. Int J Pharm 1993;95:201-207 (Pubitemid 23203153)
44. Schmidt PC, Rubensdorfer CJW. Evaluation of Ludipress as a "Multipurpose Excipient" for Direct Compression: Part I: Powder Characteristics and Tableting Properties. Drug Dev Ind Pharm 1994;20(18):2899-925 • Proof-of-concept of Ludipress as a "Multi-purpose excipient" for direct compression of tablets.
45. Schmidt PC, Rubensdorfer CJW. Evaluation of Ludipress as a "Multipurpose Excipient" for Direct Compression: Part II: Interactive blending and tableting with micronized Glibenclamide. Drug Dev Ind Pharm 1994;20(18):2927-2952
46. Baykara T, Duman G, Ozesener KS, et al. Comparing the compressibility of using Acetaminophen as an active ingredient. Drug Dev Ind Pharm 1991;17:2359-2371
47. Heinz R, Wolf H, Schuchmann H, et al. Formulation and development of tablets based on Ludipress and scale-up from laboratory to production scale. Drug Dev Ind Pharm 2000;26(5):513-521 (Pubitemid 30225629)
48. Microcelac 100. Available from: http://www.meggle-pharma.de/en/products/ uebersicht/microcelac100. [Accessed]
49. Garr JS, Rubinstein MH. Compaction Properties of a Cellulose-Lactose Direct Compression Excipient. Pharm Tech Int 1991;3:24-27
50. Belda PM, Mielck JB. The tabletting behaviour of Cellactose® compared with mixtures of celluloses with lactoses. Eur J Pharm Biopharm 1996;42(5):325-330 (Pubitemid 26384367)
51. Arida Adi I, Al-Tabakha MM. Cellactose® a Co-processed Excipient: A Comparison Study. Pharm Dev Technol 2008;13:165-75 • Clearly explains the differences in the compaction properties between microcyrstalline cellulose, cellactose, and physical mixture of alpha-lactose monohydrate and microcyrstalline cellulose.
52. Gohel MC, Jogani PD. Exploration of Melt Granulation Technique for the Development of Coprocessed Directly Compressible Adjuvant Containing Lactose and Microcrystalline Cellulose. Pharm Dev Technol 2003;8(2 ):175-185 (Pubitemid 36548982)
53. Michoel A, Rombaut P, Verhoye A. Comparative evaluation of co-processed lactose and microcrystalline cellulose with their physical mixtures in the formulation of folic acid tablets. Pharm Dev Technol 2002;7(1):79-87 (Pubitemid 35154417)
54. Muzíková J, Zvolánková J. A study of the properties of tablets from coprocessed dry binders composed of alpha-lactose monohydrate and different types of cellulose. Ceska Slov Farm 2007;56(6):269-275
55. Hauschild K, Picker KM. Evaluation of a new co-processed compound based on lactose and maize starch for tablet formulation. AAPS PharmSci 2004;6:27-38 • 3-D model has been used to evaluate and analyze the deformation behavior of new coprocessed compound based on lactose and maize starch.
56. Gohel MC, Jogani PD. An Investigation in Direct Compression Characteristics of Co-processed Lactose-Starch using Experimental Design. Indian J Pharm Sci 2003;65:31-38
57. Luukkonen P, Schaefer T, Hellén L, et al. Rheological characterization of microcrystalline cellulose and silicified microcrystalline cellulose wet masses using a mixer torque rheometer. Int J Pharm 1999;188(2):181-192 (Pubitemid 29486721)
58. Fraser SD, Michael T, Stephan E, et al. Physicochemical comparison between microcrystalline cellulose and silicified microcrystalline cellulose. Int J pharm 1998;169:183-194 (Pubitemid 28345254)
59. Buckton G, Yonemochi E, Yoonb WL, Moffatb AC. Water sorption and near IR spectroscopy to study the differences between microcrystalline cellulose and silicified microcrystalline cellulose before and after wet granulation. Int J Pharm 1999;181(1):41-47 (Pubitemid 29199886)
60. Muzíková J, Nováková P. A Study of the Properties of Compacts from Silicified Microcrystalline Celluloses. Drug Dev Ind Pharm 2007;33(7):775-781 (Pubitemid 47123805)
61. Edge S, Steele DF, Chen A, et al. The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose. Int J Pharm 2000;200(1):67-72 • Proof-of-concept of functionality benefits of silicification to microcrystalline cellulose. (Pubitemid 30177251)
62. Lahdenpää E, Antikainen O, Yliruusi J. Direct compression with silicified and non-silicified microcrystalline cellulose: study of some properties of powders and tablets. STP Pharma Sciences 2001;11(2):129-135 (Pubitemid 32274919)
63. Kachrimanis K, Nikolakakis I, Malamataris S. Tensile strength and disintegration of tableted silicified microcrystalline cellulose: Influences of interparticle bonding. J Pharm Sci 2003;92(7):1489-1501 (Pubitemid 36792761)
64. Steele DF, Edge S, Tobyn MJ, et al. Adsorption of an Amine Drug onto Microcrystalline Cellulose and Silicified Microcrystalline Cellulose Samples. Drug Dev Ind Pharm 2003;29(4):475-487 (Pubitemid 36528614)
65. Avicel CE15. In: Rowe RC, Sheskey PJ, Owen SC, editors, Pharmaceutical excipients, 2005. p. 348-349
66. Mehara DK, West KP, Wiggins JD, inventors; FMC Corporation, assignee. Coprocessed microcrystaline cellulose and calcium carbonate and its preparation. US; 1988
67. Limwong V, Sutanthavibul N, Kulvanich P. Spherical composite particles of rice starch and microcrystalline cellulose: A new co-processed excipient for direct compression. AAPS PharmSciTech 2004;5(2):E30 (Pubitemid 41086228)
68. Li J, Carlin B, Ruszkay T. FMC Corporation(Philadelphia) assignee. Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations. Patent 20080131505; 2008
69. Jacob S, Shirwaikar AA, Joseph A, Srinivasan KK. Novel co-processed excipients of mannitol and microcrystalline cellulose for preparing fast dissolving tablets for Glipizide. Indian J Pharm Sci 2007;69(5):633-639
70. Harris D, Amin A. Compressol S- A Novel Direct Compression Excipient for the Nutraceutical Market. AAPS Annual Meeting and Exposition. T2262; 2006
71. Norman GT, Nuguru KS, Amin AF, Chandar S. SPI Pharma, Inc., assignee. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms. Patent 20060251716; 2006
72. Koivurinta JH. Suomen Sokeri Oy (Finnish Sugar Company Ltd.)(FI), assignee Binder-diluent composition and method. US4698101; 1987
73. Advantose FS 95. Available from: http://www.spipharma.com/downloads/ Products/Excipients/Advantose-FS95/103AdvantoseFructose-tech.pdf.
74. Bhargava HN, Mendes RW. Lozenges. In: Swarbrick, Swarbrick J, Boylan JC, editors, Encyclopedia of Pharmaceutical Technology: Liposomes as Pharmaceutical Dosage Forms to Microencapsulation. Volume 9. New York London: Informa Health Care, 1994. p. 65-86
75. Xylitab. Available from: http://abstracts.aapspharmaceutica.com/ expoaaps06/ec/forms/attendee/index.aspx?content=vbooth&id=195
76. Formaxx. Available from: http://www.rona.biz/lifescience/literature/ Formaxx%20Co-processed%20Calcium%20Carbonate.pdf
77. Freitag F, Runge J, Kleinebudde P. Coprocessing of Powdered Cellulose and Magnesium Carbonate: Direct Tableting Versus Tableting After Roll Compaction/Dry Granulation. Pharm Dev Technol 2005;10(3):353-362 (Pubitemid 41291472)
78. Adeagbo AA, Alebiowu G. Evaluation of Cocoa Butter as Potential Lubricant for Coprocessing in Pharmaceutical Tablets. Pharm Dev Technol 2008;13(3):197-204 (Pubitemid 351882240)
79. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Preparation and Assessment of Novel Coprocessed Superdisintegrant Consisting of Crospovidone and Sodium Starch Glycolate: A Technical Note. AAPS PharmSciTech 2007;8(1):E1-7
80. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the Tablet Characteristics and Dissolution Profile of Ibuprofen by Using a Novel Coprocessed Superdisintegrant: A Technical Note. AAPS PharmSciTech 2007;8(1):E1-6 (Pubitemid 46335542)
81. Casalderrey M, Souto C, Concheiro A, et al. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients. Chem Pharm Bull (Tokyo) 2004;52(4):398-401 (Pubitemid 41694721)
82. Guidance for industry; Nonclinical studies for the safety evaluation of Pharmaceutical Excipients: published by US Department of Health and Human resources, FDA, CDER, and CBER; 2005 • Guidance regarding nonclinical studies for the safety evaluation of pharmaceutical excipients has been dealt.
83. Pico RG, Sullivan TM. Regulation of Pharmaceutical Excipients. In: Katdare A, Chaubal M, editors, Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems: CRC Press, 2006. p. 37-50